Predicted serotype-specific effectiveness of pneumococcal conjugate vaccines V114 and PCV20 against invasive pneumococcal disease in children

• Hlavní autoři: Josiah Ryman (Autor), Jeffrey R. Sachs (Autor), Ka Lai Yee (Autor), Natalie Banniettis (Autor), Jessica Weaver (Autor), Thomas Weiss (Autor)
• Médium: Kniha
• Vydáno: Taylor & Francis Group, 2024-12-01T00:00:00Z.
• Témata: article
• On-line přístup: Connect to this object online.

ABSTRACTBackground Next-generation, higher-valency pneumococcal conjugate vaccines (PCVs), 15-valent PCV V114 and 20-valent PCV (PCV20), have been assessed by comparing their immune responses across serotypes shared with the 13-valent PCV (PCV13). Without efficacy or real-world vaccine effectiveness...